External broker reports(aggregated public sources), MNC Sekuritas

MNC Sekuritas

MNC Sekuritas, the first wholly-owned subsidiary established by the Group back in 1989, provides a complete range of services, from equity, fixed income, investment banking to providing research to optimize clients’ investments. Thus far, the company has more than 140 points of sales with over 100,000 clients. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Equity Bottom-Up

<ul><li>Revenue slightly declined by -0.8% YoY to IDR1.69 trillion in 1Q25 (vs IDR1.71 trillion in 1Q24), implying 22.8%/22.5% achievement MNCS/consensus estimates in FY25E.</li><li>Impacted by a high base from last year's dengue fever outbreak and fewer working days in the quarter. Inpatient revenue fell by 3.7% YoY, while outpatient revenue decreased by 1.2% YoY. </li><li>Inpatient days declined by 5% YoY to 496k in 1Q25 (vs 522k in 1Q24), and outpatient visits dropped by 4% YoY to 2.1 million (vs 2.2 million in 1Q24), mainly due to fewer effective working days. </li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Revenue slightly declined by -0.8% YoY to IDR1.69 trillion in 1Q25 (vs IDR1.71 trillion in 1Q24), implying 22.8%/22.5% achievement MNCS/consensus estimates in FY25E.Impacted by a high base from last year's dengue fever outbreak and fewer working days in the quarter. Inpatient revenue fell by 3.7% YoY, while outpatient revenue decreased by 1.2% YoY. Inpatient days declined by 5% YoY to 496k in 1Q25 (vs 522k in 1Q24), and outpatient visits dropped by 4% YoY to 2.1 million (vs 2.2 million in 1Q24), mainly due to fewer effective working days. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Heal IJ - Near-Term Pressure, Medium-Term Promise

Medikaloka Hermina

Heal IJ - Near-Term Pressure, Medium-Term Promise